Abstract | OBJECTIVE: MATERIALS AND METHODS: RESULTS: The addition of calcium to the culture medium enhanced the secretion of MIP-1alpha from ATL cells, which was inhibited by the CaM-KK inhibitor. The transfection of CaM-KIV stimulated MIP-1alpha promoter activity, and the upstream kinase CaM-KK enhanced the stimulatory effect of CaM-KIV on the promoter activity. Mutation in the cyclic adenosine 5' monophosphate response element (CRE) within the MIP-1alpha promoter significantly reduced the effect of CaM-KIV, and CRE mutant promoter activity was not significantly enhanced by the addition of calcium to the culture medium as compared to wild-type promoter activity. CONCLUSION:
Hypercalcemia enhances MIP-1alpha secretion in ATL cells, and this mechanism requires the involvement of CaM-KK/CaM-KIV cascade through the CRE. These findings raise a possibility that the inhibitory effect of CaM-KK/CaM-KIV cascade may be a potential therapeutic target for ATL.
|
Authors | Kensuke Matsumoto, Koji Murao, Hitomi Imachi, Takamasa Nishiuchi, Wenming Cao, Xiao Yu, Junhua Li, Rania A M Ahmed, Hisakazu Iwama, Ryoji Kobayashi, Hiroshi Tokumitsu, Toshihiko Ishida |
Journal | Experimental hematology
(Exp Hematol)
Vol. 36
Issue 4
Pg. 390-400
(Apr 2008)
ISSN: 0301-472X [Print] Netherlands |
PMID | 18249060
(Publication Type: Journal Article)
|
Chemical References |
- Benzimidazoles
- Chemokine CCL3
- Enzyme Inhibitors
- Isoquinolines
- Naphthalimides
- STO 609
- Calcium-Calmodulin-Dependent Protein Kinase Kinase
- Calcium-Calmodulin-Dependent Protein Kinases
- Calcium
|
Topics |
- Benzimidazoles
(pharmacology)
- Calcium
(pharmacology)
- Calcium-Calmodulin-Dependent Protein Kinase Kinase
(antagonists & inhibitors)
- Calcium-Calmodulin-Dependent Protein Kinases
(metabolism)
- Cell Line, Tumor
- Chemokine CCL3
(genetics, metabolism)
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
(pharmacology)
- Gene Expression Regulation, Leukemic
(drug effects)
- Humans
- Isoquinolines
(pharmacology)
- Leukemia, T-Cell
(drug therapy, metabolism)
- Naphthalimides
(pharmacology)
- Phosphorylation
(drug effects)
- Promoter Regions, Genetic
- Signal Transduction
(drug effects)
|